Company intelligence / Profile preview

Niti Medical Technologies

Ownership: Private
Development stage: Commercial

Overview

NiTi Medical Technologies has developed nitinol-based surgical devices—such as ColonRing™ and Hand CAC™ 30—for compression anastomosis in gastrointestinal surgery. These products are FDA-cleared and CE-marked. Clinical evidence from thousands of cases worldwide demonstrates seamless healing, strong anastomotic integrity, low complication rates, and natural expulsion of the device without patient discomfort.

Therapeutic areas: OncologyGastroenterology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Not specifically listed; supported by leading surgeons globally and venture investors including Millennium Materials Technologies Fund

Beyond the preview

Go deeper on Niti Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niti Medical Technologies.

Explore the full profile